Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have been diagnosed with primary open-angle glaucoma (a common type of glaucoma where fluid drainage in the eye is reduced), or people with no history of glaucoma (who would participate as a comparison group)
- People whose eye examination shows an open drainage angle in the eye (a specific measurement called Shaffer grade 3 or 4)
- People whose vision, when corrected with glasses or contact lenses, is 20/25 or better
- People whose prescription falls within a moderate range — between +3.00 and -5.00 diopters (not too far-sighted or too short-sighted)
- People who have never previously used eye drop medications for glaucoma
- People diagnosed with high-pressure glaucoma (eye pressure of 22 mmHg or higher recorded on 3 visits), normal-pressure glaucoma (eye pressure of 21 mmHg or lower recorded on 3 visits), or people with a healthy optic nerve and normal visual fields who are a similar age to those with glaucoma (comparison group)
Who may not be able to join:
- People with corneal (front surface of the eye) problems that could interfere with certain pressure-measurement tests used in the trial
- People with retinal diseases that affect the nerve fibre layer of the eye (for example, conditions causing pulling or traction on the central part of the retina)
- People who have had any previous eye surgery or laser treatment to the eye
- People who have been diagnosed with diabetes
- People with a history of uveitis (inflammation inside the eye)
- People who have used steroid medications (such as cortisone or prednisone) for a long period of time
- People with neurological or other whole-body conditions such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, or schizophrenia
- People whose visual field test results are considered unreliable
- People who have medical reasons why they cannot take a type of medication called beta blockers — for example, a very slow heart rate or severe lung disease
- People with moderate to severe glaucoma, based on a specific grading system used by eye specialists (Hodapp-Anderson-Parrish criteria)
- People who have a history of wearing contact lenses
- People with low blood pressure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Osamah Saeedi, MD, University of Maryland, Baltimore
Phone: 16672141232
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Corneal Biomechanical Modulus
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.